Articles From: Nutraceutical Reports Fiscal 2013 Q2 Results to Acorda Therapeutics to Host Conference Call to Discuss First Quarter 2013 Financial Results on May 2, 2013

PARK CITY, Utah , April 25, 2013 /PRNewswire/ -- Nutraceutical International Corporation (NASDAQ:   NUTR) today reported results for the fiscal 2013 second quarter ended March 31, 2013 .

NeuroMetrix, Inc. (Nasdaq: NURO) , a medical device company focused on the treatment of diabetic peripheral neuropathy (DPN), today reported business and financial highlights for the first quarter ended March 31, 2013.

FIRST QUARTER 2013 FINANCIAL RESULTS WHO: Gary Kelly , Chairman of the Board, President, and Chief Executive Officer Tammy Romo , Senior Vice President Finance & Chief Financial Officer WHAT: Following the question and answer portion of a call dedicated to an audience of investors/financial analysts, members of the media will be given an opportunity to ask questions of Mr.

SOUTHFIELD, Mich.

Kobo Aura HD now available at Indigo Canada NewsWire Kobo Creates New High-Definition eReader for the Passionate Booklover TORONTO , April 25, 2013 /CNW/ - (TSX: IDG) - Kobo Inc. has announced the launch of the Kobo Aura HD, a limited edition eReader designed for the passionate book lover, available for purchase in-store and online starting today.

Industry Leaders Join Forces to Cross-Sell and Collaborate on Expert-Driven Talent Management Services Worldwide NAPERVILLE, Ill.

ConocoPhillips (NYSE: COP) today reported first-quarter 2013 earnings of $2.1 billion, or $1.73 per share, compared with first-quarter 2012 earnings of $2.9 billion, or $2.27 per share.

Broadwind Energy, Inc. (NASDAQ: BWEN) will announce first-quarter results Thursday, May 9, 2013, before market open.

L-3 Communications Holdings, Inc. (NYSE: LLL) today reported diluted earnings per share (diluted EPS) from continuing operations of $2.11 for the quarter ended March 29, 2013 (2013 first quarter), an increase of 13%, compared to $1.86 for the quarter ended March 30, 2012 (2012 first quarter). The 2013 first quarter included a $10 million ($0.11 per diluted share) tax benefit for the retroactive reinstatement of the U.S. Federal research and experimentation tax credit related to the 2012 tax year.

HIGHLIGHTS - Company Reports First Quarter 2013 Revenues of $49.9 million - Q1 2013 Adjusted Earnings Per Diluted Share of $0.08 - Summer Blockbuster Season Kicks off This Week with International Release of Iron Man 3 NEW YORK , April 25, 2013 /PRNewswire/ -- IMAX Corporation (NYSE:IMAX; TSX:IMX) today reported first quarter 2013 revenues of $49.9 million , adjusted EBITDA as calculated in accordance with the Company's credit facility of $13.9 million , adjusted net income of $5.6 million , or $0.08 per diluted share, and reported net income of $2.9 million , or $0.04 per diluted share.

-- Sales of $1.68 billion --

PITTSBURGH , April 25, 2013 /PRNewswire/ -- CONSOL Energy Inc. (NYSE: CNX) , the leading diversified fuel producer in the Eastern United States , earned an adjusted $0.19 per share 1 , which is a non-GAAP measure, after adjusting for certain items not generally included in security analysts' estimates.

Bemis Company, Inc. (NYSE:BMS) today reported first quarter 2013 diluted earnings of $0.47 per share on net sales of $1.3 billion.

Salix Pharmaceuticals, Ltd.

Optimized for CEVA-MM3101 imaging and vision platform, new Super-Resolution algorithm brings PC-equivalent performance to low power devices MOUNTAIN VIEW, Calif.

NATICK, Mass.

BERWYN, Pa.

Amedisys, Inc. (NASDAQ: AMED) , one of America’s leading home health and hospice care companies, today announced preliminary financial results for the first quarter ended March 31, 2013.

Amorfix to investigate lung cancer misfolded proteins for therapeutic intervention Canada NewsWire TSX: AMF TORONTO , April 25, 2013 /CNW/ - Amorfix Life Sciences announced today that it has signed a collaboration agreement with The University of Texas MD Anderson Cancer Center for the use of the Company's anti-cancer antibodies in a lung cancer research program.

DUBLIN, Ohio , April 25, 2013 /PRNewswire/ -- Cardinal Health said today that it has signed new agreements to supply pharmaceuticals to a network of CVS Caremark Corporation's retail pharmacies and distribution centers through mid-2016.

Canadian Western Trust to act as custodian for GP Wealth Management's Signature Service Accounts Canada NewsWire "CWT is excited to partner with GP Wealth's financial advisors, through our self-directed fee-for-service platform, to offer GP Wealth's Signature Service Account," says Patricia Hunter , National Sales Manager for CWT.

Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an asset purchase agreement to acquire the Healthcare Protective Products Division (HPPD) of Bracco Diagnostics Inc. in an all-cash transaction that includes payment of $26.0 million upon closing.

McKesson Corporation (NYSE: MCK) announced that is has renewed its current distribution agreement with CVS Caremark.

Awards presentation will mark recipients' exceptional achievements in customer experience, business performance, security, and innovative solution implementation RA'ANANA, Israel , April 25, 2013 /PRNewswire/ -- NICE Systems (NASDAQ: NICE) today announced the winners of the 2013 NICE Customer Excellence Awards, recognizing outstanding achievements across the following categories: business impact, customer experience, implementation, security, and overall portfolio.

EQT Corporation (NYSE: EQT) today announced first quarter 2013 earnings of $100.3 million, or $0.66 per diluted share; compared to first quarter 2012 earnings of $72.0 million, or $0.48 per diluted share.

KANSAS CITY, Mo.

BEDMINSTER, N.J. , April 25, 2013 /PRNewswire/ -- The Board of Directors of GAIN Capital Holdings, Inc. (NYSE: GCAP) , a global provider of online trading services, today announced that it has rejected an unsolicited written proposal from FXCM Inc. to acquire GAIN for 0.3996 shares of FXCM Class A common stock for each share of GAIN common stock.

- Transformative acquisition provides significant scale along with revenue and product diversification - Combined 2013 revenue run-rate of $329 million and pro forma EBITDA run-rate of $77 million based on Q1 2013 results - Pro forma client assets of approximately $650 million and funded accounts of 139,710 as of March 31, 2013 - Estimated first year operating synergies of $35-$45 million - Accretive in the first full quarter following closing BEDMINSTER, N.J. , April 25, 2013 /PRNewswire/ --  GAIN Capital Preliminary First Quarter 2013 Results: Revenues increased 50% year-over year, to $49.8 million EBITDA of $7.5 million , up from $1.3 million ; 15% EBITDA margin Net income of $4.3 million , or $0.11 per diluted share Client assets reached $456.9 million ; Funded accounts increased 36% to 100,020 GAIN Capital Holdings, Inc. (NYSE: GCAP, "the Company") today announced that it has signed a definitive

AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2013 second quarter, ended March 31, 2013, diluted earnings per share from continuing operations were $0.87, a 4 percent increase.

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will host a conference call and live webcast to report its first quarter 2013 financial results on Thursday, May 2 at 8:30 a.m. ET.